PGR and breast cancer: Niedźwiecki et al. [66] compared the serum expression of oncomiRs miR-21, miR-10b and of miR-200c, the downregulation of which was described as cell migration and metastasis promoter, in 46 TN and ER+/PR+ BC patients.